Lancashire Teaching Hospitals NHS Trust Signs Pounds Sterling 8.3 Million Contract to Implement Patient1 Electronic Patient Record System.

Business Editors

LINCOLN, United Kingdom--(BUSINESS WIRE)--Aug. 22, 2002

Merging Trust Chooses Patient1(r) Clinical Information and

EPR Solution Supplied by Per-Se Technologies

Per-Se Technologies Inc., through Per-Se Technologies (UK) Ltd., its Lincoln-based international office, today announced the signing of a contract with Lancashire Teaching Hospitals NHS Trust.

Included in the agreement is a fully managed onsite electronic patient record (EPR) service, with Per-Se's award-winning Patient1 integrated EPR solution at its core. With approximately 1,300 beds, Lancashire Teaching Hospitals is one of the largest trusts in the U.K., serving nearly 400,000 people in the northwest of England and attracting a regional population of almost two million to specialty services like neurosurgery, burns and cancer treatment.

Patient1 is an integrated, patient-centred clinical information system that optimises care processes across the continuum. It provides an enterprise-wide infrastructure that unifies lifetime healthcare and medical care record information into a single electronic health record to achieve the cost-effective delivery of quality patient care and clinical outcomes.

Lancashire Teaching Hospitals' Patient1 implementation is a broad-ranging, multi-site project being phased in over a three-year period to meet the Level 3 EPR deadline in 2005. The first priority will be to consolidate the merged Trust's new patient administration system (PAS) requirements with electronic case notes, radiology, A&E, theatres and pathology results. Subsequent phases include ward order entry and results reporting (with GP web access) followed by e-prescribing (with Patient1's unique proactive alerts), e-pharmacy and care pathways.

The Trust and Per-Se designed the implementation strategy to maximise benefit realisation opportunities for the Trust and will continually refine it to eventually touch all aspects of patient care. Per-Se brings to the partnership broad-based benefit realisation experience because it has implemented many similar EPR systems worldwide based on the principles of value-for-money and a cost-justifiable business case.

Len Slawinski, managing director of Per-Se's UK office, explained some of the background to the decision: "Lancashire Teaching Hospitals selected Patient1 after four years of evaluating EPR systems and their choice was based on several considerations. As a merging Trust with multiple sites, a major systems rationalisation was going to be needed, compounded by the fact that many departmental systems were reaching the end of their life cycle. Providing local and regional communication links for sharing patient information was another priority with five other acutes and 12 community facilities in the vicinity, as well as up to 25 Trusts in the catchment for speciality services."

Said Karen B. Andrews, president of Per-Se's Application Software division: "We are extremely pleased to have been chosen to partner with such a prestigious healthcare organisation in the development of this landmark EPR programme. We believe our Patient1 EPR is a clinical solution uniquely suited to the needs of the NHS modernisation agenda, and we look forward to working with Lancashire Teaching Hospitals NHS Trust in providing a beacon to others. This contract is also a first step in our UK-wide initiative to put EPR solutions within the reach of most Acute Hospital Trusts by offering value for money alongside the highest quality provisioning."

Editors Note:

About Lancashire Teaching Hospitals NHS Trust

On 1 August 2002, the Chorley and South Ribble NHS Trust and the Preston Acute Hospitals NHS Trust merged to become the Lancashire Teaching Hospitals NHS Trust. The Trust comprises three hospitals: Chorley and South Ribble District General, Royal Preston and Sharoe Green, with a total bed capacity of 1265. These facilities provide a full range of acute outpatient and inpatient services to 380,000 people living in Central Lancashire with specialist services extended to 1.5 million people in the Lancashire and South Cumbria area. Specialties include cancer, neurosciences, renal medicine, burns and plastic surgery.

About Per-Se Technologies

Per-Se Technologies, Inc (Nasdaq: PSTI) is a global leader in delivering integrated clinical and financial software solutions, comprehensive business management services and Internet-enabled connectivity. Per-Se enables primary and acute environments to simultaneously optimise the quality of care delivered and the profitability of business operations. Based in the United States, Per-Se Technologies supports more than 47,000 GPs and consultants and 2,000 healthcare organisations and manages 26 million patient lives online. UK offices are based in Lincoln. For more information visit www.per-se.com.

Safe Harbor Statement

This Press Release contains statements that constitute forward-looking statements within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Forward-looking statements contained in this Press Release include the intent, belief or current expectations of the Company and members of its management team with respect to the Company's future business operations and the assumptions upon which such statements are based. Forward-looking statements include specifically, but are not limited to, revenue projections, contract value projections and the time period of new sales implementations. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance, and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. For significant software sales, the Company recognizes revenue on a percentage of completion basis over the life of the contract. Important factors currently known to management that could cause actual results to differ materially from those contemplated by the forward-looking statements in this Press Release include, but are not limited to, failure to successfully implement new sales within contract-specified timeframes and hit contract-specified milestones, therefore, adversely affecting revenue recognition and factors with respect to the operation or performance of the Company's business units or the market price of its common stock. Additional factors that would cause actual results to differ materially from those contemplated within this Press Release can also be found in the Company's Safe Harbor Compliance Statement included in the Company's Form 10-K for the year ended December 31, 2001 and Form 10-Q for the quarter ended June 30, 2002. The Company disclaims any responsibility to update any forward-looking statements.

Editor's Note: Per-Se Technologies is a registered trademark of Per-Se Technologies, Inc., and Patient1 is a registered trademark of PST Products, Inc., d/b/a Per-Se Technologies.